Evidence map›Paper›PMID 24100481›Full record

ReviewCirculation2013

Coronary artery revascularization in patients with diabetes mellitus.

Ehrin J Armstrong, John C Rutledge, Jason H Rogers

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Circulation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2020
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Life after Coronary Artery Bypass Grafting: Lifestyle Changes, Secondary Prevention, and Quality of Life.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Review
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.Clinical medicine insights. Endocrinology and diabetes · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ehrin J ArmstrongUniversity of California, Davis Medical Center, Division of Cardiovascular Medicine, Sacramento.
John C Rutledge
Jason H Rogers
University of California Davis Medical Center · US

Funding

Interactions of Lipoproteins with the Vascular WallR01HL055667 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI RUTLEDGE, JOHN CALVERT · 1996 to 2010
$2.8M
Brain Microvascular Determinants of Alzheimers DiseaseR01AG039094 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RUTLEDGE, JOHN CALVERT · 2010 to 2014
$2.1M
NHLBI NIH HHS R01 HL055667NIA NIH HHS AG039094NIA NIH HHS R01 AG039094
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary DiseaseDiabetic AngiopathiesHumansMyocardial RevascularizationPrevalenceRisk Factorsdiabetes mellitusmyocardial revascularizationpercutaneous coronary intervention

Identifiers

PMID24100481
PMCPMC3901842
OpenAlexW2132004730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.